artizia 0,075 mg/0,020 mg obalené tablety
zentiva, k.s., Česká republika - gestodén a etinylestradiol - 17 - anticoncipientia
barla podpazušná drevená
Ľubomír Ševčík majsl < & Šimonovianska 21 958 03 partizánske slovensko -
monitor svalovej relaxácie mr-1095
kalas medical, s.r.o. < § slovenských partizánov 1130/50, p.o.box 48/a 017 01 považská bystrica slovensko -
stolička toaletná hygienická astra
Ľubomír Ševčík majsl < & Šimonovianska 21 958 03 partizánske slovensko -
stolička toaletná hygienická duha
Ľubomír Ševčík majsl < & Šimonovianska 21 958 03 partizánske slovensko -
stolička toaletná hygienická perla
Ľubomír Ševčík majsl < & Šimonovianska 21 958 03 partizánske slovensko -
rúško 3 - vrstvové ochranné chirurgické nano ms3-nano-iir
medical sixtine s.r.o. partizánska 73 957 01 bánovce nad bebravou slovensko -
kĹbová výŽiva – artroregen
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, hydrochlorid metformín - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pre dostupné údaje o rôznych kombináciách).
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - chrípky vírusu povrchové antigény (hemaglutinínu a neuraminidázy) kmeňa a/vietnam/1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vakcíny - aktívna imunizácia proti podtypu h5n1 vírusu chrípky a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.